Selinexor-dexamethasone for refractory multiple myeloma

Lancet Oncol. 2019 Oct;20(10):e560. doi: 10.1016/S1470-2045(19)30566-2. Epub 2019 Aug 30.
No abstract available

Publication types

  • News

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Clinical Trials, Phase I as Topic
  • Dexamethasone / administration & dosage
  • Humans
  • Hydrazines / administration & dosage
  • Multicenter Studies as Topic
  • Multiple Myeloma / drug therapy*
  • Retreatment
  • Triazoles / administration & dosage

Substances

  • Hydrazines
  • Triazoles
  • selinexor
  • Dexamethasone